• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在全科实践中为药剂师提供资金:一项为未来经济评估设计提供信息的可行性研究。

Funding pharmacists in general practice: A feasibility study to inform the design of future economic evaluations.

机构信息

Discipline of Pharmacy, Faculty of Health, University of Canberra, Bruce, Canberra, ACT, 2617, Australia.

Discipline of Pharmacy, Faculty of Health, University of Canberra, Bruce, Canberra, ACT, 2617, Australia.

出版信息

Res Social Adm Pharm. 2021 May;17(5):1012-1016. doi: 10.1016/j.sapharm.2020.07.030. Epub 2020 Aug 10.

DOI:10.1016/j.sapharm.2020.07.030
PMID:32847733
Abstract

BACKGROUND

Funding is a significant barrier to employing general practice pharmacists.

OBJECTIVE(S): To explore the feasibility of determining the cost-benefit of pharmacists in Australian general practice.

METHODS

Two part-time pharmacists were employed by general practices in Canberra, Australia. Diaries of the pharmacists were analysed to determine time worked and participation in income-generating activities, including Government-funded programs: Asthma Cycle of Care, Home Medicine Reviews, and Health Care Assessments. Scenarios using different practice and business models were entered into value-cost models to determine the income generated by the pharmacists relative to their salary.

RESULTS

Over 19 weeks, pharmacists A and B supported 47 and 23 Asthma Cycle of Care activities, generating income to the general practice of AU$4,700 and AU$2,300, respectively. The pharmacists spent 36.4 and 24.1 hours on activities usually conducted by general practitioners (GPs), allowing additional time for GP-patient consultations. Value-cost models determined AU$0.61 - AU$1.20 income generation by pharmacists per AU$1 salary.

CONCLUSIONS

It was feasible to determine the value-cost ratios of employing pharmacists in general practice using these methods. Future work should focus on developing a robust business model that includes health care system savings resulting from practice pharmacist interventions, determined from randomised controlled trials.

摘要

背景

资金是在全科医疗中雇用执业药师的一个重大障碍。

目的

探索确定澳大利亚全科医疗中药师成本效益的可行性。

方法

两名兼职药师受雇于澳大利亚堪培拉的全科诊所。对药师的日记进行分析,以确定工作时间和参与创收活动的情况,包括政府资助的项目:哮喘周期护理、家庭药物审查和医疗评估。使用不同的实践和商业模式的场景被输入价值成本模型,以确定药师的收入相对于他们的工资。

结果

在 19 周内,药师 A 和 B 支持了 47 项和 23 项哮喘周期护理活动,分别为全科医疗带来了 4700 澳元和 2300 澳元的收入。药师们花费了 36.4 小时和 24.1 小时从事通常由全科医生(GP)进行的活动,为 GP-患者咨询留出了额外的时间。价值成本模型确定了药师每 1 澳元工资可产生 0.61 澳元至 1.20 澳元的收入。

结论

使用这些方法确定在全科医疗中雇用药师的成本效益比值是可行的。未来的工作应侧重于开发一个稳健的商业模式,该模式包括通过随机对照试验确定从执业药师干预中节省的医疗保健系统成本。

相似文献

1
Funding pharmacists in general practice: A feasibility study to inform the design of future economic evaluations.在全科实践中为药剂师提供资金:一项为未来经济评估设计提供信息的可行性研究。
Res Social Adm Pharm. 2021 May;17(5):1012-1016. doi: 10.1016/j.sapharm.2020.07.030. Epub 2020 Aug 10.
2
New ways of working releasing general practitioner capacity with pharmacy prescribing support: a cost-consequence analysis.新的工作方式通过药剂师处方支持释放全科医生的能力:成本-效益分析。
Fam Pract. 2022 Jul 19;39(4):648-655. doi: 10.1093/fampra/cmab175.
3
Evaluating the potential outcomes of pharmacist-led activities in the Australian general practice setting: a prospective observational study.评估药剂师主导的活动在澳大利亚全科医疗环境中的潜在效果:一项前瞻性观察研究。
Int J Clin Pharm. 2023 Aug;45(4):980-988. doi: 10.1007/s11096-023-01604-x. Epub 2023 Jun 3.
4
What can pharmacists do in general practice? A pilot trial.药剂师在全科医疗中能做什么?一项试点试验。
Aust J Gen Pract. 2018 Aug;47(8):545-549. doi: 10.31128/AJGP-03-18-4520.
5
The value of pharmacists in general practice: perspectives of general practitioners-an exploratory interview study.全科医疗中药剂师的价值:全科医生的观点——一项探索性访谈研究
Int J Clin Pharm. 2019 Apr;41(2):496-503. doi: 10.1007/s11096-019-00795-6. Epub 2019 Mar 12.
6
Integration of pharmacists into general practice clinics in Australia: the views of general practitioners and pharmacists.澳大利亚药剂师融入全科诊所:全科医生和药剂师的观点。
Int J Pharm Pract. 2014 Feb;22(1):28-37. doi: 10.1111/ijpp.12047. Epub 2013 Jun 11.
7
Economic cost-benefit analysis of person-centred medicines reviews by general practice pharmacists.全科药师开展以患者为中心的药物治疗管理的成本效益分析。
Int J Clin Pharm. 2024 Aug;46(4):957-965. doi: 10.1007/s11096-024-01732-y. Epub 2024 May 30.
8
Feasibility of a collaborative pharmacist prescribing model for patients with chronic disease(s) attending Australian general practices: a preliminary study.澳大利亚全科医疗中慢性病患者的药剂师协作开方模式可行性:一项初步研究。
Int J Clin Pharm. 2023 Apr;45(2):502-508. doi: 10.1007/s11096-022-01488-3. Epub 2022 Nov 7.
9
Barriers and enablers to collaborative working between GPs and pharmacists: a qualitative interview study.全科医生与药剂师之间协作的障碍和促进因素:一项定性访谈研究。
Br J Gen Pract. 2020 Feb 27;70(692):e155-e163. doi: 10.3399/bjgp20X708197. Print 2020 Mar.
10
Perceived feasibility of a community pharmacy-based asthma intervention: a qualitative follow-up study.基于社区药店的哮喘干预措施的可感知可行性:一项定性随访研究。
J Clin Pharm Ther. 2011 Jun;36(3):348-55. doi: 10.1111/j.1365-2710.2010.01187.x. Epub 2010 Oct 19.

引用本文的文献

1
Evaluating the potential outcomes of pharmacist-led activities in the Australian general practice setting: a prospective observational study.评估药剂师主导的活动在澳大利亚全科医疗环境中的潜在效果:一项前瞻性观察研究。
Int J Clin Pharm. 2023 Aug;45(4):980-988. doi: 10.1007/s11096-023-01604-x. Epub 2023 Jun 3.
2
Value-based primary care in Australia: how far have we travelled?澳大利亚的基于价值的初级保健:我们走了多远?
Med J Aust. 2022 Jun 6;216 Suppl 10(Suppl 10):S24-S27. doi: 10.5694/mja2.51530.
3
General practice pharmacists in Australia: A systematic review.
澳大利亚的全科药师:系统评价。
PLoS One. 2021 Oct 14;16(10):e0258674. doi: 10.1371/journal.pone.0258674. eCollection 2021.
4
Principles of pharmacoeconomic analysis: the case of pharmacist-led interventions.药物经济学分析原理:以药师主导的干预措施为例。
Pharm Pract (Granada). 2021 Jan-Mar;19(1):2302. doi: 10.18549/PharmPract.2021.1.2302. Epub 2021 Feb 22.